2,286
Views
13
CrossRef citations to date
0
Altmetric
Review

Prioritization schema for immunotherapy clinical trials in glioblastoma

, , , , , , , , , , , , , , , , , , & show all
Article: e1145332 | Received 16 Nov 2015, Accepted 16 Jan 2016, Published online: 23 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Dandan Fan, Qi Yue, Jian Chen, Cong Wang, Ruilin Yu, Ziyi Jin, Shujie Yin, Qinyue Wang, Luo Chen, Xueling Liao, Chengyuan Peng, Jianpin Zhang, Zhonglian Cao, Ying Mao, Ruimin Huang, Liang Chen & Cong Li. (2021) Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells. OncoImmunology 10:1.
Read now
Abhishek D. Garg, Monica Vara Perez, Marco Schaaf, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Dendritic cell-based anticancer immunotherapy. OncoImmunology 6:7.
Read now

Articles from other publishers (11)

Kavitha Godugu, Bruce A Hay, Gennadi V Glinsky & Shaker A Mousa. (2023) Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme. Neuro-Oncology Advances 5:1.
Crossref
Michael I. Dorrell, Heidi R. Kast-Woelbern, Ryan T. Botts, Stephen A. Bravo, Jacob R. Tremblay, Sarah Giles, Jessica F. Wada, MaryAnn Alexander, Eric Garcia, Gabriel Villegas, Caylor B. Booth, Kaitlyn J. Purington, Haylie M. Everett, Erik N. Siles, Michael Wheelock, Jordan A. Silva, Bridget M. Fortin, Connor A. Lowey, Allison L. Hale, Troy L. Kurz, Jack C. Rusing, Dawn M. Goral, Paul Thompson, Alec M. Johnson, Daniel J. Elson, Roujih Tadros, Charisa E. Gillette, Carley Coopwood, Amy L. Rausch & Jeffrey M. Snowbarger. (2021) A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis. PLOS ONE 16:6, pages e0252233.
Crossref
Michelle N Meyer, Luke Gelinas, Barbara E Bierer, Sara Chandros Hull, Steven Joffe, David Magnus, Seema Mohapatra, Richard R Sharp, Kayte Spector-Bagdady, Jeremy Sugarman, Benjamin S Wilfond & Holly Fernandez Lynch. (2021) An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clinical Trials 18:2, pages 226-233.
Crossref
Martina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, Ling-Yuan Kong, Jun Wei, Maya Duna, Katia Blumberg, Xiaorong Ji, Carmen Jacobs, Gregory N. Fuller, Lauren A. Langford, Jason T. Huse, James P. Long, Jian Hu, Shulin Li, Jeffrey S. Weinberg, Sujit S. Prabhu, Raymond Sawaya, Sherise Ferguson, Ganesh Rao, Frederick F. Lang, Michael A. Curran & Amy B. Heimberger. (2020) Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight 5:17.
Crossref
Wei Shi, Qianqian Qiu, Zhenzhen Tong, Weiwei Guo, Feng Zou, Ziying Feng, Yao Wang, Wenlong Huang & Hai Qian. (2020) Synthetic tumor-specific antigenic peptides with a strong affinity to HLA-A2 elicit anti-breast cancer immune response through activating CD8+ T cells. European Journal of Medicinal Chemistry 189, pages 112051.
Crossref
Michaël Hananja Meel, Gertjan J.L. Kaspers & Esther Hulleman. (2019) Preclinical therapeutic targets in diffuse midline glioma. Drug Resistance Updates 44, pages 15-25.
Crossref
Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, Rémi Rosière, Abhishek D. Garg, Patrizia Agostinis, Véronique Mathieu, Robert Kiss, Florence Lefranc, Louis Boon, Jochen Belmans, Stefaan W. Van Gool, Holger Gerhardt, Karim Amighi & Steven De Vleeschouwer. (2017) Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy. Scientific Reports 7:1.
Crossref
Visish M. Srinivasan, Sherise D. Ferguson, Sungho Lee, Shiao-Pei Weathers, Brittany C. Parker Kerrigan & Amy B. Heimberger. (2017) Tumor Vaccines for Malignant Gliomas. Neurotherapeutics 14:2, pages 345-357.
Crossref
Aaron C. Tan, Amy B. Heimberger & Mustafa Khasraw. (2017) Immune Checkpoint Inhibitors in Gliomas. Current Oncology Reports 19:4.
Crossref
Frank Lieberman. (2017) Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials. F1000Research 6, pages 1892.
Crossref
Tiffany R Hodges, Sherise D Ferguson & Amy B Heimberger. (2016) Immunotherapy in glioblastoma: emerging options in precision medicine. CNS Oncology 5:3, pages 175-186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.